NATIONAL BRIEFING / NATIONWIDE
Times Wire Reports
A drug that can selectively target and kill the stem cells that may drive the growth of tumors has been identified.
Researchers at Massachusetts Institute of Technology and the Broad Institute looked for compounds that could destroy the stem cells, which often resist conventional cancer treatment.
One, salinomycin, cut the number of stem cells at least 100 times more than did Taxol, a common chemotherapy medicine, according to a report in the journal Cell.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
